Default company panoramic image
7255ae56 9085 475f 8676 2be142af7d3f


Pulmostics manufacturers breath analysis equipment to diagnose disease. The company's focus is early detection of Sepsis and other diseases.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Thousand Oaks, CA, USA
  • Currency USD
  • Founded January 2014
  • Employees 4
  • Website

Company Summary

Pulmostics provides breath analysis tools and services to diagnose disease through analysis of alveolar air. Sepsis, lung cancer, breast cancer, diabetes, leukemia and other diseases have been shown to have a distinctive gas profile in a patients lungs. Pulmostic's initial diagnostic service will be for Sepsis, a hidden killer. Nearly 1.6M people are diagnosed with sepsis annually. 30% die. Sepsis costs about USD 20,000 per patient.


  • Default avatar
    Teong Lim

    Dr Lim is an accomplished serial entrepreneur. From Amgen, to Amerasia, to Crystal Clear Technologies and Electronic Sensor Technology Dr Lim has been engaged in companies in therapeutics, sensors and displays.

  • Default avatar
    Hongxi Hui
    Medical Advisor

    Dr Hui has published over 150 peer reviewed papers on metabolic disease. He is Professor and Director: International Center for Metabolic Diseases, Southern Medical University, SMU Institute of Biotherapy, SMU Institute of Metabolic Science . He also holds the position of Principle Scientist UCLA Center of Excellence Metabolic Disease UCLA David Geffen School of Medicine Veteran Medical Center, Los Angeles

  • Default avatar
    William Wittmeyer

    Financial and Operational Executive with full life cycle experience from Start up to IPO. International business development in China and Southeast Asia. Technology experience in semiconductor, instrumentation communications and software. Chief Operating Officer of Electronic Sensor Technology.

  • Default avatar
    Steve Wang
    CFO and China Operations

    Senior International Business Executive experienced in all phases of business development from start-up through initial public offering. Extensive business cross border transaction experience (US and China) and business development experience in China. Serial entrepreneur with several start-ups in health care industry, include China Health Care Acquisition, an AMEX listed company